

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axon ensheathment in central nervous system (GO:0032291) | 5.90714731 |
| 2 | central nervous system myelination (GO:0022010) | 5.90714731 |
| 3 | fatty acid elongation (GO:0030497) | 5.78808776 |
| 4 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.23663877 |
| 5 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.80313198 |
| 6 | respiratory electron transport chain (GO:0022904) | 4.55447594 |
| 7 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.46298299 |
| 8 | ATP synthesis coupled proton transport (GO:0015986) | 4.46298299 |
| 9 | electron transport chain (GO:0022900) | 4.42750251 |
| 10 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.38392554 |
| 11 | L-phenylalanine catabolic process (GO:0006559) | 4.38392554 |
| 12 | regulation of relaxation of muscle (GO:1901077) | 4.34834417 |
| 13 | muscle filament sliding (GO:0030049) | 4.26939042 |
| 14 | actin-myosin filament sliding (GO:0033275) | 4.26939042 |
| 15 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.26315000 |
| 16 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.16335248 |
| 17 | regulation of cell communication by electrical coupling (GO:0010649) | 4.06848377 |
| 18 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.96926470 |
| 19 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.92328535 |
| 20 | L-phenylalanine metabolic process (GO:0006558) | 3.92328535 |
| 21 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.89943149 |
| 22 | regulation of cholesterol esterification (GO:0010872) | 3.88507221 |
| 23 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.82105620 |
| 24 | oxaloacetate metabolic process (GO:0006107) | 3.80850223 |
| 25 | cholesterol biosynthetic process (GO:0006695) | 3.78024919 |
| 26 | thioester biosynthetic process (GO:0035384) | 3.77609727 |
| 27 | acyl-CoA biosynthetic process (GO:0071616) | 3.77609727 |
| 28 | regulation of actin filament-based movement (GO:1903115) | 3.73326210 |
| 29 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.71725230 |
| 30 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.69406544 |
| 31 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.68229733 |
| 32 | high-density lipoprotein particle remodeling (GO:0034375) | 3.56561789 |
| 33 | cardiac muscle contraction (GO:0060048) | 3.52764366 |
| 34 | cellular ketone body metabolic process (GO:0046950) | 3.51811776 |
| 35 | creatine metabolic process (GO:0006600) | 3.51399016 |
| 36 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.50142421 |
| 37 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.48640433 |
| 38 | acetyl-CoA metabolic process (GO:0006084) | 3.48413822 |
| 39 | plasma lipoprotein particle remodeling (GO:0034369) | 3.43018484 |
| 40 | protein-lipid complex remodeling (GO:0034368) | 3.43018484 |
| 41 | macromolecular complex remodeling (GO:0034367) | 3.43018484 |
| 42 | very long-chain fatty acid metabolic process (GO:0000038) | 3.42026726 |
| 43 | thioester metabolic process (GO:0035383) | 3.39814827 |
| 44 | acyl-CoA metabolic process (GO:0006637) | 3.39814827 |
| 45 | oxidative phosphorylation (GO:0006119) | 3.39189610 |
| 46 | actin-mediated cell contraction (GO:0070252) | 3.38009539 |
| 47 | heart contraction (GO:0060047) | 3.37615193 |
| 48 | heart process (GO:0003015) | 3.37615193 |
| 49 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.36069142 |
| 50 | chaperone-mediated protein transport (GO:0072321) | 3.35926991 |
| 51 | phospholipid homeostasis (GO:0055091) | 3.32550257 |
| 52 | sterol biosynthetic process (GO:0016126) | 3.31096403 |
| 53 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.30717719 |
| 54 | aromatic amino acid family catabolic process (GO:0009074) | 3.30604439 |
| 55 | reverse cholesterol transport (GO:0043691) | 3.29633227 |
| 56 | aldehyde catabolic process (GO:0046185) | 3.27131328 |
| 57 | striated muscle contraction (GO:0006941) | 3.26198313 |
| 58 | cofactor catabolic process (GO:0051187) | 3.23767200 |
| 59 | short-chain fatty acid metabolic process (GO:0046459) | 3.23188723 |
| 60 | protein neddylation (GO:0045116) | 3.13804092 |
| 61 | myelination (GO:0042552) | 3.12886312 |
| 62 | ensheathment of neurons (GO:0007272) | 3.12253278 |
| 63 | axon ensheathment (GO:0008366) | 3.12253278 |
| 64 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.11771100 |
| 65 | myofibril assembly (GO:0030239) | 3.08801057 |
| 66 | aspartate family amino acid catabolic process (GO:0009068) | 3.07937917 |
| 67 | ketone body metabolic process (GO:1902224) | 3.07716168 |
| 68 | sarcomere organization (GO:0045214) | 3.07689610 |
| 69 | response to methylmercury (GO:0051597) | 3.05857635 |
| 70 | glyoxylate metabolic process (GO:0046487) | 3.03203352 |
| 71 | regulation of protein activation cascade (GO:2000257) | 3.02446205 |
| 72 | coenzyme catabolic process (GO:0009109) | 3.00742929 |
| 73 | branched-chain amino acid catabolic process (GO:0009083) | 3.00407565 |
| 74 | blood coagulation, intrinsic pathway (GO:0007597) | 3.00225671 |
| 75 | cardiac myofibril assembly (GO:0055003) | 2.99385778 |
| 76 | amino acid salvage (GO:0043102) | 2.94764327 |
| 77 | L-methionine salvage (GO:0071267) | 2.94764327 |
| 78 | L-methionine biosynthetic process (GO:0071265) | 2.94764327 |
| 79 | substantia nigra development (GO:0021762) | 2.93909644 |
| 80 | negative regulation of protein localization to cell surface (GO:2000009) | 2.93850876 |
| 81 | fatty acid beta-oxidation (GO:0006635) | 2.91360972 |
| 82 | ubiquinone biosynthetic process (GO:0006744) | 2.90898689 |
| 83 | fatty acid catabolic process (GO:0009062) | 2.90290054 |
| 84 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.89968621 |
| 85 | detection of calcium ion (GO:0005513) | 2.88888467 |
| 86 | acylglycerol homeostasis (GO:0055090) | 2.88450133 |
| 87 | triglyceride homeostasis (GO:0070328) | 2.88450133 |
| 88 | glycerophospholipid catabolic process (GO:0046475) | 2.87701913 |
| 89 | regulation of complement activation (GO:0030449) | 2.85670112 |
| 90 | regulation of skeletal muscle contraction (GO:0014819) | 2.83959763 |
| 91 | response to redox state (GO:0051775) | 2.83774571 |
| 92 | quinone biosynthetic process (GO:1901663) | 2.81857169 |
| 93 | glutathione biosynthetic process (GO:0006750) | 2.79562011 |
| 94 | isoprenoid biosynthetic process (GO:0008299) | 2.79088105 |
| 95 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.79078429 |
| 96 | hydrogen ion transmembrane transport (GO:1902600) | 2.78899657 |
| 97 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.77931541 |
| 98 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.77931541 |
| 99 | fatty acid transmembrane transport (GO:1902001) | 2.77061001 |
| 100 | bile acid biosynthetic process (GO:0006699) | 2.76780223 |
| 101 | cardiac muscle hypertrophy (GO:0003300) | 2.75830955 |
| 102 | regulation of striated muscle contraction (GO:0006942) | 2.74572167 |
| 103 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.74541913 |
| 104 | tricarboxylic acid cycle (GO:0006099) | 2.74197762 |
| 105 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.72354896 |
| 106 | alpha-linolenic acid metabolic process (GO:0036109) | 2.70783446 |
| 107 | heme transport (GO:0015886) | 2.70451746 |
| 108 | cholesterol efflux (GO:0033344) | 2.70366867 |
| 109 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.69237074 |
| 110 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.67603504 |
| 111 | proton transport (GO:0015992) | 2.66697214 |
| 112 | amyloid precursor protein metabolic process (GO:0042982) | 2.66460335 |
| 113 | low-density lipoprotein particle remodeling (GO:0034374) | 2.65636884 |
| 114 | hydrogen transport (GO:0006818) | 2.65523913 |
| 115 | fatty acid oxidation (GO:0019395) | 2.65018627 |
| 116 | lipid oxidation (GO:0034440) | 2.64799662 |
| 117 | monocarboxylic acid catabolic process (GO:0072329) | 2.64623164 |
| 118 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.64494538 |
| 119 | complement activation, alternative pathway (GO:0006957) | 2.64040977 |
| 120 | gluconeogenesis (GO:0006094) | 2.63859911 |
| 121 | striated muscle hypertrophy (GO:0014897) | 2.63256336 |
| 122 | regulation of lipoprotein metabolic process (GO:0050746) | 2.62730968 |
| 123 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.62553635 |
| 124 | NADH metabolic process (GO:0006734) | 2.62518359 |
| 125 | peroxisome fission (GO:0016559) | 2.62389496 |
| 126 | presynaptic membrane organization (GO:0097090) | 2.62140259 |
| 127 | skeletal muscle contraction (GO:0003009) | 2.61883657 |
| 128 | 2-oxoglutarate metabolic process (GO:0006103) | 2.61180262 |
| 129 | triglyceride biosynthetic process (GO:0019432) | 2.60824651 |
| 130 | plasma lipoprotein particle clearance (GO:0034381) | 2.60024602 |
| 131 | succinate metabolic process (GO:0006105) | 2.59842191 |
| 132 | ubiquinone metabolic process (GO:0006743) | 2.59049285 |
| 133 | ATP biosynthetic process (GO:0006754) | 2.58621456 |
| 134 | phospholipid efflux (GO:0033700) | 2.58417646 |
| 135 | cysteine metabolic process (GO:0006534) | 2.58176650 |
| 136 | dicarboxylic acid catabolic process (GO:0043649) | 2.57212328 |
| 137 | branched-chain amino acid metabolic process (GO:0009081) | 2.55207071 |
| 138 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.53879580 |
| 139 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.53347801 |
| 140 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.53347801 |
| 141 | NADH dehydrogenase complex assembly (GO:0010257) | 2.53347801 |
| 142 | biotin metabolic process (GO:0006768) | 2.53192043 |
| 143 | acylglycerol biosynthetic process (GO:0046463) | 2.52613021 |
| 144 | neutral lipid biosynthetic process (GO:0046460) | 2.52613021 |
| 145 | glutathione derivative biosynthetic process (GO:1901687) | 2.52364924 |
| 146 | glutathione derivative metabolic process (GO:1901685) | 2.52364924 |
| 147 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.51036196 |
| 148 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.51036196 |
| 149 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.47970412 |
| 150 | protein complex biogenesis (GO:0070271) | 2.47629765 |
| 151 | glutathione metabolic process (GO:0006749) | 2.47395649 |
| 152 | myelin maintenance (GO:0043217) | 2.46728847 |
| 153 | regulation of sequestering of triglyceride (GO:0010889) | 2.46609955 |
| 154 | negative regulation of neurotransmitter transport (GO:0051589) | 2.46126643 |
| 155 | amyloid precursor protein catabolic process (GO:0042987) | 2.44819912 |
| 156 | regulation of triglyceride catabolic process (GO:0010896) | 2.44558953 |
| 157 | tyrosine metabolic process (GO:0006570) | 2.44402534 |
| 158 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.43186799 |
| 159 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.42659904 |
| 160 | aromatic amino acid family metabolic process (GO:0009072) | 2.42402757 |
| 161 | establishment of mitochondrion localization (GO:0051654) | 2.41982673 |
| 162 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.40562199 |
| 163 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.39806767 |
| 164 | nucleotide transmembrane transport (GO:1901679) | 2.39602808 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.87454329 |
| 2 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.30580189 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.23029338 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.77185216 |
| 5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.63567092 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.38407266 |
| 7 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.36828516 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.27779862 |
| 9 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.22805055 |
| 10 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.21539202 |
| 11 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.96031429 |
| 12 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.93465337 |
| 13 | VDR_22108803_ChIP-Seq_LS180_Human | 1.92882348 |
| 14 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.91279967 |
| 15 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.89768416 |
| 16 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.88308766 |
| 17 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.87073541 |
| 18 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.85803919 |
| 19 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.84363087 |
| 20 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.83809513 |
| 21 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.78039861 |
| 22 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.76587253 |
| 23 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.73569919 |
| 24 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.69263007 |
| 25 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.65968312 |
| 26 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.62098163 |
| 27 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.60511270 |
| 28 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.59186363 |
| 29 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.58141368 |
| 30 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.57644700 |
| 31 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.55867765 |
| 32 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.55516906 |
| 33 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.52362572 |
| 34 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.49044399 |
| 35 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.45838306 |
| 36 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.43107124 |
| 37 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.42191159 |
| 38 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.42191159 |
| 39 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.38196931 |
| 40 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.37669871 |
| 41 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.36694356 |
| 42 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.34666806 |
| 43 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.33097981 |
| 44 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.32685529 |
| 45 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.31498300 |
| 46 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.30069519 |
| 47 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.28430539 |
| 48 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.25942139 |
| 49 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.24868408 |
| 50 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.24802265 |
| 51 | P300_19829295_ChIP-Seq_ESCs_Human | 1.24247416 |
| 52 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.22776178 |
| 53 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.20229407 |
| 54 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.18573474 |
| 55 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.18452083 |
| 56 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.17735965 |
| 57 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.15873248 |
| 58 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.14558001 |
| 59 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.12728249 |
| 60 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.11980132 |
| 61 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11246484 |
| 62 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.11233941 |
| 63 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.10553785 |
| 64 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.09848590 |
| 65 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.09639337 |
| 66 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.08496852 |
| 67 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.08496852 |
| 68 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.08434037 |
| 69 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.07110672 |
| 70 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.06977502 |
| 71 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.05626755 |
| 72 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.05626755 |
| 73 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.05080239 |
| 74 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.05070588 |
| 75 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.04491616 |
| 76 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.03978504 |
| 77 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.03978504 |
| 78 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.03373241 |
| 79 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.03063650 |
| 80 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.02848167 |
| 81 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.01406837 |
| 82 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.01062591 |
| 83 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.00325456 |
| 84 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.99608240 |
| 85 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.99580291 |
| 86 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.97978709 |
| 87 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.97728772 |
| 88 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.96742329 |
| 89 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.96322463 |
| 90 | GATA1_22025678_ChIP-Seq_K562_Human | 0.96310203 |
| 91 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.95400462 |
| 92 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.95372671 |
| 93 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.95185295 |
| 94 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.95155533 |
| 95 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.94478774 |
| 96 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.94220282 |
| 97 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.93497768 |
| 98 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.92497240 |
| 99 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.91991898 |
| 100 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.91913380 |
| 101 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.91790987 |
| 102 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.91752506 |
| 103 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.91649245 |
| 104 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.91615929 |
| 105 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.91411139 |
| 106 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.91229123 |
| 107 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.90372805 |
| 108 | CBP_21632823_ChIP-Seq_H3396_Human | 0.90273394 |
| 109 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.89862507 |
| 110 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.89459720 |
| 111 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.89121974 |
| 112 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.89080693 |
| 113 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.89060486 |
| 114 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.89053407 |
| 115 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.88421932 |
| 116 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.88299381 |
| 117 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.87806644 |
| 118 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.87337857 |
| 119 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.87280714 |
| 120 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.86432726 |
| 121 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.86120954 |
| 122 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.86000343 |
| 123 | AR_20517297_ChIP-Seq_VCAP_Human | 0.85966654 |
| 124 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.85143321 |
| 125 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.85082701 |
| 126 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.84615868 |
| 127 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.84417174 |
| 128 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.82942727 |
| 129 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.82917480 |
| 130 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.82850506 |
| 131 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.82672673 |
| 132 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.81767079 |
| 133 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.81236556 |
| 134 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.81214917 |
| 135 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.81092062 |
| 136 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.81004725 |
| 137 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.80674675 |
| 138 | NCOR_22424771_ChIP-Seq_293T_Human | 0.80614116 |
| 139 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.80479756 |
| 140 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.80216287 |
| 141 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.80193556 |
| 142 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.80186146 |
| 143 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.80058178 |
| 144 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.79133249 |
| 145 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.79116928 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 3.47854699 |
| 2 | MP0003806_abnormal_nucleotide_metabolis | 3.28352409 |
| 3 | MP0005360_urolithiasis | 3.08785149 |
| 4 | MP0000920_abnormal_myelination | 3.07884439 |
| 5 | MP0003195_calcinosis | 2.92455106 |
| 6 | MP0004084_abnormal_cardiac_muscle | 2.82076978 |
| 7 | MP0005085_abnormal_gallbladder_physiolo | 2.65527228 |
| 8 | MP0003880_abnormal_central_pattern | 2.63498684 |
| 9 | MP0008875_abnormal_xenobiotic_pharmacok | 2.61833717 |
| 10 | MP0002837_dystrophic_cardiac_calcinosis | 2.53845087 |
| 11 | MP0005365_abnormal_bile_salt | 2.34551474 |
| 12 | MP0003690_abnormal_glial_cell | 2.28417000 |
| 13 | MP0001529_abnormal_vocalization | 2.24437189 |
| 14 | MP0004043_abnormal_pH_regulation | 2.13967847 |
| 15 | MP0003329_amyloid_beta_deposits | 2.12386895 |
| 16 | MP0005332_abnormal_amino_acid | 2.08957888 |
| 17 | MP0005451_abnormal_body_composition | 2.08610643 |
| 18 | MP0004484_altered_response_of | 2.01533302 |
| 19 | MP0006036_abnormal_mitochondrial_physio | 1.97994793 |
| 20 | MP0001905_abnormal_dopamine_level | 1.94220250 |
| 21 | MP0003646_muscle_fatigue | 1.88526435 |
| 22 | MP0009840_abnormal_foam_cell | 1.84845856 |
| 23 | MP0003950_abnormal_plasma_membrane | 1.83528844 |
| 24 | MP0004270_analgesia | 1.79719586 |
| 25 | MP0002638_abnormal_pupillary_reflex | 1.76033325 |
| 26 | MP0004142_abnormal_muscle_tone | 1.75629251 |
| 27 | MP0002272_abnormal_nervous_system | 1.71306168 |
| 28 | MP0003186_abnormal_redox_activity | 1.69142351 |
| 29 | MP0003137_abnormal_impulse_conducting | 1.64833595 |
| 30 | MP0009046_muscle_twitch | 1.63764107 |
| 31 | MP0008260_abnormal_autophagy | 1.63487067 |
| 32 | MP0000604_amyloidosis | 1.60364192 |
| 33 | MP0002064_seizures | 1.59964246 |
| 34 | MP0008775_abnormal_heart_ventricle | 1.57121699 |
| 35 | MP0002118_abnormal_lipid_homeostasis | 1.55403376 |
| 36 | MP0002269_muscular_atrophy | 1.55311522 |
| 37 | MP0004147_increased_porphyrin_level | 1.55085031 |
| 38 | MP0004130_abnormal_muscle_cell | 1.53023142 |
| 39 | MP0002106_abnormal_muscle_physiology | 1.51468519 |
| 40 | MP0004036_abnormal_muscle_relaxation | 1.50452929 |
| 41 | MP0005385_cardiovascular_system_phenoty | 1.49634840 |
| 42 | MP0001544_abnormal_cardiovascular_syste | 1.49634840 |
| 43 | MP0005646_abnormal_pituitary_gland | 1.47217239 |
| 44 | MP0003656_abnormal_erythrocyte_physiolo | 1.47045924 |
| 45 | MP0010329_abnormal_lipoprotein_level | 1.47003828 |
| 46 | MP0004087_abnormal_muscle_fiber | 1.44455192 |
| 47 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.44393666 |
| 48 | MP0005171_absent_coat_pigmentation | 1.41679878 |
| 49 | MP0005083_abnormal_biliary_tract | 1.40683486 |
| 50 | MP0001486_abnormal_startle_reflex | 1.38420775 |
| 51 | MP0002876_abnormal_thyroid_physiology | 1.37887305 |
| 52 | MP0001661_extended_life_span | 1.36897648 |
| 53 | MP0005535_abnormal_body_temperature | 1.34946806 |
| 54 | MP0009745_abnormal_behavioral_response | 1.34392067 |
| 55 | MP0003191_abnormal_cellular_cholesterol | 1.31961081 |
| 56 | MP0004742_abnormal_vestibular_system | 1.29959573 |
| 57 | MP0002127_abnormal_cardiovascular_syste | 1.29103321 |
| 58 | MP0000749_muscle_degeneration | 1.29025771 |
| 59 | MP0001440_abnormal_grooming_behavior | 1.25548505 |
| 60 | MP0004085_abnormal_heartbeat | 1.24778757 |
| 61 | MP0003136_yellow_coat_color | 1.24006381 |
| 62 | MP0003634_abnormal_glial_cell | 1.21567641 |
| 63 | MP0005369_muscle_phenotype | 1.21512865 |
| 64 | MP0002822_catalepsy | 1.21387952 |
| 65 | MP0002229_neurodegeneration | 1.19268223 |
| 66 | MP0004510_myositis | 1.19094313 |
| 67 | MP0003868_abnormal_feces_composition | 1.18509721 |
| 68 | MP0005058_abnormal_lysosome_morphology | 1.18163384 |
| 69 | MP0000751_myopathy | 1.15721796 |
| 70 | MP0006035_abnormal_mitochondrial_morpho | 1.14749052 |
| 71 | MP0000372_irregular_coat_pigmentation | 1.14440472 |
| 72 | MP0002734_abnormal_mechanical_nocicepti | 1.11245013 |
| 73 | MP0004215_abnormal_myocardial_fiber | 1.10102207 |
| 74 | MP0001986_abnormal_taste_sensitivity | 1.09675270 |
| 75 | MP0006082_CNS_inflammation | 1.07404721 |
| 76 | MP0002132_abnormal_respiratory_system | 1.07254196 |
| 77 | MP0005330_cardiomyopathy | 1.06335809 |
| 78 | MP0005165_increased_susceptibility_to | 1.06063516 |
| 79 | MP0001485_abnormal_pinna_reflex | 1.04878868 |
| 80 | MP0005084_abnormal_gallbladder_morpholo | 1.03875597 |
| 81 | MP0004924_abnormal_behavior | 1.02777184 |
| 82 | MP0005386_behavior/neurological_phenoty | 1.02777184 |
| 83 | MP0003635_abnormal_synaptic_transmissio | 1.02770935 |
| 84 | MP0005266_abnormal_metabolism | 1.02600736 |
| 85 | MP0004885_abnormal_endolymph | 1.01843255 |
| 86 | MP0003633_abnormal_nervous_system | 1.01396434 |
| 87 | MP0001666_abnormal_nutrient_absorption | 1.01272793 |
| 88 | MP0001764_abnormal_homeostasis | 1.01266647 |
| 89 | MP0005636_abnormal_mineral_homeostasis | 1.00428316 |
| 90 | MP0002736_abnormal_nociception_after | 0.99814726 |
| 91 | MP0000759_abnormal_skeletal_muscle | 0.99444483 |
| 92 | MP0000343_altered_response_to | 0.99123101 |
| 93 | MP0002735_abnormal_chemical_nociception | 0.98862192 |
| 94 | MP0006138_congestive_heart_failure | 0.98861996 |
| 95 | MP0000747_muscle_weakness | 0.98551713 |
| 96 | MP0001501_abnormal_sleep_pattern | 0.98232059 |
| 97 | MP0002090_abnormal_vision | 0.98216281 |
| 98 | MP0003631_nervous_system_phenotype | 0.98171903 |
| 99 | MP0004185_abnormal_adipocyte_glucose | 0.96565915 |
| 100 | MP0005645_abnormal_hypothalamus_physiol | 0.94900740 |
| 101 | MP0004019_abnormal_vitamin_homeostasis | 0.94727782 |
| 102 | MP0002572_abnormal_emotion/affect_behav | 0.94672522 |
| 103 | MP0005408_hypopigmentation | 0.94327309 |
| 104 | MP0002078_abnormal_glucose_homeostasis | 0.94210488 |
| 105 | MP0006276_abnormal_autonomic_nervous | 0.94101992 |
| 106 | MP0003879_abnormal_hair_cell | 0.92722196 |
| 107 | MP0002067_abnormal_sensory_capabilities | 0.92628437 |
| 108 | MP0005666_abnormal_adipose_tissue | 0.91844938 |
| 109 | MP0001970_abnormal_pain_threshold | 0.91776426 |
| 110 | MP0000013_abnormal_adipose_tissue | 0.91292800 |
| 111 | MP0000230_abnormal_systemic_arterial | 0.91001425 |
| 112 | MP0003632_abnormal_nervous_system | 0.90025408 |
| 113 | MP0003724_increased_susceptibility_to | 0.89610194 |
| 114 | MP0008872_abnormal_physiological_respon | 0.89111594 |
| 115 | MP0000750_abnormal_muscle_regeneration | 0.88331945 |
| 116 | MP0005379_endocrine/exocrine_gland_phen | 0.88302940 |
| 117 | MP0009643_abnormal_urine_homeostasis | 0.88141742 |
| 118 | MP0002332_abnormal_exercise_endurance | 0.86907434 |
| 119 | MP0002971_abnormal_brown_adipose | 0.86130460 |
| 120 | MP0001968_abnormal_touch/_nociception | 0.86100050 |
| 121 | MP0001756_abnormal_urination | 0.85921177 |
| 122 | MP0005319_abnormal_enzyme/_coenzyme | 0.85750035 |
| 123 | MP0004859_abnormal_synaptic_plasticity | 0.85501939 |
| 124 | MP0003011_delayed_dark_adaptation | 0.84576662 |
| 125 | MP0010630_abnormal_cardiac_muscle | 0.84154322 |
| 126 | MP0008995_early_reproductive_senescence | 0.84001621 |
| 127 | MP0005620_abnormal_muscle_contractility | 0.83771267 |
| 128 | MP0002063_abnormal_learning/memory/cond | 0.82850203 |
| 129 | MP0003252_abnormal_bile_duct | 0.81591973 |
| 130 | MP0005410_abnormal_fertilization | 0.80804509 |
| 131 | MP0002066_abnormal_motor_capabilities/c | 0.80612216 |
| 132 | MP0004145_abnormal_muscle_electrophysio | 0.80397188 |
| 133 | MP0005670_abnormal_white_adipose | 0.80317905 |
| 134 | MP0005551_abnormal_eye_electrophysiolog | 0.80023854 |
| 135 | MP0005253_abnormal_eye_physiology | 0.80003889 |
| 136 | MP0002972_abnormal_cardiac_muscle | 0.79328477 |
| 137 | MP0001984_abnormal_olfaction | 0.78318607 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 4.81929244 |
| 2 | Acute encephalopathy (HP:0006846) | 4.54817191 |
| 3 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.45338032 |
| 4 | Progressive macrocephaly (HP:0004481) | 4.08705284 |
| 5 | Mitochondrial inheritance (HP:0001427) | 4.05805828 |
| 6 | Sudden death (HP:0001699) | 3.97266912 |
| 7 | Cerebral edema (HP:0002181) | 3.91194996 |
| 8 | Muscle fiber inclusion bodies (HP:0100299) | 3.80930058 |
| 9 | Hepatocellular necrosis (HP:0001404) | 3.77516205 |
| 10 | Hepatic necrosis (HP:0002605) | 3.76857424 |
| 11 | Nemaline bodies (HP:0003798) | 3.67646979 |
| 12 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.62956603 |
| 13 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.56390466 |
| 14 | Increased CSF lactate (HP:0002490) | 3.55138816 |
| 15 | Bundle branch block (HP:0011710) | 3.54956073 |
| 16 | Neurofibrillary tangles (HP:0002185) | 3.45365593 |
| 17 | Leukodystrophy (HP:0002415) | 3.27491053 |
| 18 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.24688254 |
| 19 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.24688254 |
| 20 | Exercise-induced muscle cramps (HP:0003710) | 3.22643029 |
| 21 | Pheochromocytoma (HP:0002666) | 3.15935614 |
| 22 | Parakeratosis (HP:0001036) | 3.15128893 |
| 23 | Rhabdomyolysis (HP:0003201) | 3.06936630 |
| 24 | Renal Fanconi syndrome (HP:0001994) | 3.04683382 |
| 25 | Neuroendocrine neoplasm (HP:0100634) | 3.01279581 |
| 26 | Cerebral hemorrhage (HP:0001342) | 2.93652329 |
| 27 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.93469291 |
| 28 | Abnormality of the calf musculature (HP:0001430) | 2.91177784 |
| 29 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.90983683 |
| 30 | Abnormality of glycine metabolism (HP:0010895) | 2.90983683 |
| 31 | EMG: myopathic abnormalities (HP:0003458) | 2.86546443 |
| 32 | Respiratory failure (HP:0002878) | 2.85521733 |
| 33 | Lipid accumulation in hepatocytes (HP:0006561) | 2.85513373 |
| 34 | 3-Methylglutaconic aciduria (HP:0003535) | 2.84303913 |
| 35 | Hyperlipoproteinemia (HP:0010980) | 2.83928997 |
| 36 | Lethargy (HP:0001254) | 2.80051214 |
| 37 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.76255457 |
| 38 | Increased hepatocellular lipid droplets (HP:0006565) | 2.76236093 |
| 39 | Complement deficiency (HP:0004431) | 2.74238311 |
| 40 | Increased muscle lipid content (HP:0009058) | 2.73904775 |
| 41 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.73364026 |
| 42 | Dicarboxylic aciduria (HP:0003215) | 2.73364026 |
| 43 | * Lactic acidosis (HP:0003128) | 2.73084239 |
| 44 | Intrahepatic cholestasis (HP:0001406) | 2.72712414 |
| 45 | Increased intramyocellular lipid droplets (HP:0012240) | 2.70835264 |
| 46 | Methylmalonic acidemia (HP:0002912) | 2.69912685 |
| 47 | Sensory axonal neuropathy (HP:0003390) | 2.67616075 |
| 48 | Hyporeflexia of lower limbs (HP:0002600) | 2.65014641 |
| 49 | Xanthomatosis (HP:0000991) | 2.60763612 |
| 50 | Hyperglycinuria (HP:0003108) | 2.60198823 |
| 51 | Nausea (HP:0002018) | 2.60111650 |
| 52 | Asymmetric septal hypertrophy (HP:0001670) | 2.57096431 |
| 53 | * Increased serum pyruvate (HP:0003542) | 2.55771563 |
| 54 | * Abnormality of glycolysis (HP:0004366) | 2.55771563 |
| 55 | Ketosis (HP:0001946) | 2.53333812 |
| 56 | Palpitations (HP:0001962) | 2.52995164 |
| 57 | Optic disc pallor (HP:0000543) | 2.52626045 |
| 58 | Ragged-red muscle fibers (HP:0003200) | 2.51314549 |
| 59 | Methylmalonic aciduria (HP:0012120) | 2.51221328 |
| 60 | Heart block (HP:0012722) | 2.49893306 |
| 61 | Hyperglycinemia (HP:0002154) | 2.49714123 |
| 62 | Syncope (HP:0001279) | 2.49317897 |
| 63 | Hyperammonemia (HP:0001987) | 2.48193798 |
| 64 | Axonal loss (HP:0003447) | 2.44549015 |
| 65 | Prolonged partial thromboplastin time (HP:0003645) | 2.42876995 |
| 66 | Subaortic stenosis (HP:0001682) | 2.41713445 |
| 67 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.41713445 |
| 68 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.41530993 |
| 69 | Cerebral inclusion bodies (HP:0100314) | 2.40687305 |
| 70 | Spastic paraparesis (HP:0002313) | 2.38647708 |
| 71 | Abnormality of the corticospinal tract (HP:0002492) | 2.37383776 |
| 72 | Dilated cardiomyopathy (HP:0001644) | 2.34317118 |
| 73 | Muscle fiber splitting (HP:0003555) | 2.34120494 |
| 74 | Joint hemorrhage (HP:0005261) | 2.33927240 |
| 75 | Glycosuria (HP:0003076) | 2.32054985 |
| 76 | Abnormality of urine glucose concentration (HP:0011016) | 2.32054985 |
| 77 | Type 1 muscle fiber predominance (HP:0003803) | 2.31159855 |
| 78 | Ventricular tachycardia (HP:0004756) | 2.31057798 |
| 79 | CNS demyelination (HP:0007305) | 2.30980565 |
| 80 | Atrial fibrillation (HP:0005110) | 2.30467906 |
| 81 | Myokymia (HP:0002411) | 2.29008321 |
| 82 | Ketoacidosis (HP:0001993) | 2.26310989 |
| 83 | Vomiting (HP:0002013) | 2.24508045 |
| 84 | Ventricular arrhythmia (HP:0004308) | 2.24143419 |
| 85 | Exercise intolerance (HP:0003546) | 2.23402353 |
| 86 | Renal cortical cysts (HP:0000803) | 2.21244598 |
| 87 | Spontaneous abortion (HP:0005268) | 2.21229075 |
| 88 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.19609770 |
| 89 | Primary atrial arrhythmia (HP:0001692) | 2.18444243 |
| 90 | Hyperventilation (HP:0002883) | 2.18227696 |
| 91 | Metabolic acidosis (HP:0001942) | 2.16834347 |
| 92 | Supraventricular tachycardia (HP:0004755) | 2.16725332 |
| 93 | Ventricular fibrillation (HP:0001663) | 2.15604490 |
| 94 | Abnormal atrioventricular conduction (HP:0005150) | 2.15213530 |
| 95 | Lipoatrophy (HP:0100578) | 2.14523440 |
| 96 | Rimmed vacuoles (HP:0003805) | 2.14167501 |
| 97 | Abnormality of renal resorption (HP:0011038) | 2.13719386 |
| 98 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.12328854 |
| 99 | Deep venous thrombosis (HP:0002625) | 2.11465311 |
| 100 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.09717423 |
| 101 | Neck muscle weakness (HP:0000467) | 2.09463673 |
| 102 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.08654762 |
| 103 | Supraventricular arrhythmia (HP:0005115) | 2.08037863 |
| 104 | Abnormality of methionine metabolism (HP:0010901) | 2.07109464 |
| 105 | Abnormality of serum amino acid levels (HP:0003112) | 2.06015342 |
| 106 | Focal motor seizures (HP:0011153) | 2.05871718 |
| 107 | Exercise-induced myalgia (HP:0003738) | 2.04642467 |
| 108 | Hypobetalipoproteinemia (HP:0003563) | 2.03486336 |
| 109 | Hypolipoproteinemia (HP:0010981) | 2.02292653 |
| 110 | X-linked dominant inheritance (HP:0001423) | 2.00694643 |
| 111 | * Increased serum lactate (HP:0002151) | 2.00498859 |
| 112 | Left ventricular hypertrophy (HP:0001712) | 1.99905204 |
| 113 | Generalized aminoaciduria (HP:0002909) | 1.99354516 |
| 114 | Systemic lupus erythematosus (HP:0002725) | 1.99325398 |
| 115 | Hypokalemic alkalosis (HP:0001949) | 1.96756465 |
| 116 | Hypoglycemic coma (HP:0001325) | 1.96264479 |
| 117 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.95565159 |
| 118 | Abnormal gallbladder morphology (HP:0012437) | 1.93417512 |
| 119 | Proximal tubulopathy (HP:0000114) | 1.92074255 |
| 120 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.91680763 |
| 121 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.91680763 |
| 122 | Gout (HP:0001997) | 1.90203470 |
| 123 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.88399078 |
| 124 | Hepatosplenomegaly (HP:0001433) | 1.87722076 |
| 125 | Cholecystitis (HP:0001082) | 1.83431383 |
| 126 | Abnormal gallbladder physiology (HP:0012438) | 1.83431383 |
| 127 | Myoglobinuria (HP:0002913) | 1.82559559 |
| 128 | Paraparesis (HP:0002385) | 1.80893237 |
| 129 | Cerebral hypomyelination (HP:0006808) | 1.80453617 |
| 130 | Calf muscle hypertrophy (HP:0008981) | 1.79616544 |
| 131 | Steatorrhea (HP:0002570) | 1.79582498 |
| 132 | Fat malabsorption (HP:0002630) | 1.78922794 |
| 133 | Metabolic alkalosis (HP:0200114) | 1.78856861 |
| 134 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.78394257 |
| 135 | Prolonged neonatal jaundice (HP:0006579) | 1.77241863 |
| 136 | Onion bulb formation (HP:0003383) | 1.76430526 |
| 137 | Cholelithiasis (HP:0001081) | 1.75458919 |
| 138 | Abnormality of alanine metabolism (HP:0010916) | 1.73711741 |
| 139 | Hyperalaninemia (HP:0003348) | 1.73711741 |
| 140 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.73711741 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 5.00348574 |
| 2 | OXSR1 | 4.15433188 |
| 3 | PBK | 2.95692716 |
| 4 | TAOK3 | 2.72384170 |
| 5 | WNK4 | 2.70850242 |
| 6 | MAP4K2 | 2.50755342 |
| 7 | BCKDK | 2.48471273 |
| 8 | CASK | 2.40259215 |
| 9 | BCR | 2.28832013 |
| 10 | EPHB1 | 2.11289254 |
| 11 | ARAF | 2.08614897 |
| 12 | MST4 | 1.96575378 |
| 13 | PKN1 | 1.95275999 |
| 14 | TTN | 1.83049255 |
| 15 | PDK2 | 1.68403943 |
| 16 | PDK3 | 1.64892475 |
| 17 | PDK4 | 1.64892475 |
| 18 | CDK19 | 1.64276274 |
| 19 | MUSK | 1.63948966 |
| 20 | OBSCN | 1.62270817 |
| 21 | CCNB1 | 1.60571406 |
| 22 | LIMK1 | 1.60396208 |
| 23 | PINK1 | 1.57827298 |
| 24 | GRK7 | 1.57782636 |
| 25 | PHKG2 | 1.56215974 |
| 26 | PHKG1 | 1.56215974 |
| 27 | MAPKAPK5 | 1.49083511 |
| 28 | CSNK1G3 | 1.46666261 |
| 29 | NEK1 | 1.45414871 |
| 30 | MYLK | 1.41486869 |
| 31 | MAPKAPK3 | 1.39145022 |
| 32 | NME1 | 1.38638738 |
| 33 | MET | 1.37808226 |
| 34 | CAMK2B | 1.33396238 |
| 35 | FRK | 1.32574622 |
| 36 | EPHA4 | 1.30054018 |
| 37 | CAMK2D | 1.27189240 |
| 38 | EIF2AK1 | 1.25961686 |
| 39 | TNIK | 1.25023466 |
| 40 | SGK223 | 1.24894135 |
| 41 | SGK494 | 1.24894135 |
| 42 | CAMK2G | 1.23643199 |
| 43 | WNK1 | 1.17229332 |
| 44 | FGFR2 | 1.15918307 |
| 45 | DMPK | 1.15441349 |
| 46 | MAP3K12 | 1.15377767 |
| 47 | CSNK1A1L | 1.13012706 |
| 48 | CSNK1G2 | 1.09916727 |
| 49 | CSNK1G1 | 1.09434046 |
| 50 | STK16 | 1.07796133 |
| 51 | GRK5 | 1.06817174 |
| 52 | ABL2 | 1.06228872 |
| 53 | ERBB4 | 1.05144247 |
| 54 | FGR | 1.01109001 |
| 55 | CAMK2A | 1.00803530 |
| 56 | MAP3K5 | 0.97067442 |
| 57 | ERBB3 | 0.95662200 |
| 58 | NEK6 | 0.92970233 |
| 59 | PRKCE | 0.91724051 |
| 60 | BMPR2 | 0.90879913 |
| 61 | PRPF4B | 0.90233353 |
| 62 | MAPK13 | 0.89224920 |
| 63 | BMPR1B | 0.88915794 |
| 64 | PDPK1 | 0.87642308 |
| 65 | PRKAA2 | 0.86840273 |
| 66 | ROCK2 | 0.86797647 |
| 67 | NTRK1 | 0.85502164 |
| 68 | DYRK2 | 0.82665842 |
| 69 | MAP2K7 | 0.81345610 |
| 70 | CAMKK2 | 0.79926957 |
| 71 | PRKAA1 | 0.79882465 |
| 72 | PRKCQ | 0.79563323 |
| 73 | INSRR | 0.79147566 |
| 74 | RIPK4 | 0.78994519 |
| 75 | AKT2 | 0.78962972 |
| 76 | TESK1 | 0.78655261 |
| 77 | GRK1 | 0.77107727 |
| 78 | TXK | 0.76817555 |
| 79 | TESK2 | 0.74765682 |
| 80 | WNK3 | 0.73919791 |
| 81 | ADRBK2 | 0.73158915 |
| 82 | PIK3CA | 0.71285556 |
| 83 | MAP2K4 | 0.69952952 |
| 84 | MAPK12 | 0.68642843 |
| 85 | MST1R | 0.66290857 |
| 86 | PIM2 | 0.66227047 |
| 87 | TSSK6 | 0.63594836 |
| 88 | PNCK | 0.63251080 |
| 89 | CAMK1 | 0.62601392 |
| 90 | UHMK1 | 0.61265665 |
| 91 | CDK5 | 0.60161516 |
| 92 | PLK2 | 0.58603387 |
| 93 | DAPK2 | 0.57819701 |
| 94 | PAK6 | 0.57521047 |
| 95 | PRKACA | 0.57315655 |
| 96 | PAK3 | 0.56305710 |
| 97 | MINK1 | 0.56294713 |
| 98 | LMTK2 | 0.54267897 |
| 99 | MAP3K13 | 0.54065382 |
| 100 | MARK1 | 0.52222793 |
| 101 | IRAK2 | 0.51989539 |
| 102 | BRAF | 0.51854511 |
| 103 | KSR2 | 0.50424749 |
| 104 | MAP3K4 | 0.48865351 |
| 105 | MAP3K14 | 0.48859486 |
| 106 | PDK1 | 0.47696302 |
| 107 | ROCK1 | 0.47478938 |
| 108 | PRKCG | 0.47259419 |
| 109 | SGK1 | 0.47223350 |
| 110 | CDK14 | 0.45495083 |
| 111 | NTRK2 | 0.45490132 |
| 112 | PRKCA | 0.45479772 |
| 113 | PRKD1 | 0.44938347 |
| 114 | MAP2K6 | 0.43996234 |
| 115 | NME2 | 0.43601021 |
| 116 | PRKG1 | 0.42910171 |
| 117 | EIF2AK3 | 0.42508511 |
| 118 | EPHA3 | 0.42363408 |
| 119 | DAPK3 | 0.40101118 |
| 120 | PIK3CG | 0.39831392 |
| 121 | PRKACG | 0.39309991 |
| 122 | PRKACB | 0.38858070 |
| 123 | IRAK1 | 0.38772039 |
| 124 | DYRK1B | 0.38137666 |
| 125 | CSNK1A1 | 0.37712669 |
| 126 | NTRK3 | 0.37491599 |
| 127 | VRK1 | 0.37038939 |
| 128 | SGK2 | 0.36794506 |
| 129 | TIE1 | 0.36737361 |
| 130 | STK24 | 0.36133887 |
| 131 | ILK | 0.35445327 |
| 132 | STK4 | 0.35118007 |
| 133 | DAPK1 | 0.34394013 |
| 134 | CDK15 | 0.34156406 |
| 135 | CDK18 | 0.33955360 |
| 136 | CSNK2A1 | 0.33345576 |
| 137 | PTK2B | 0.33324825 |
| 138 | ACVR1B | 0.33217840 |
| 139 | RPS6KA3 | 0.32396991 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.59418823 |
| 2 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.39998324 |
| 3 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.20910173 |
| 4 | Parkinsons disease_Homo sapiens_hsa05012 | 2.77661381 |
| 5 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.75767634 |
| 6 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.68974583 |
| 7 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.66994868 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.47567119 |
| 9 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.47242148 |
| 10 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.42444642 |
| 11 | Alzheimers disease_Homo sapiens_hsa05010 | 2.21007824 |
| 12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.10570642 |
| 13 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.03604728 |
| 14 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.98646233 |
| 15 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.96545816 |
| 16 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.92275276 |
| 17 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.92003672 |
| 18 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.91466229 |
| 19 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.84857048 |
| 20 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.82761506 |
| 21 | Peroxisome_Homo sapiens_hsa04146 | 1.80566333 |
| 22 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.80010137 |
| 23 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.79849801 |
| 24 | Huntingtons disease_Homo sapiens_hsa05016 | 1.68854015 |
| 25 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.67309483 |
| 26 | Histidine metabolism_Homo sapiens_hsa00340 | 1.66589622 |
| 27 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.59874399 |
| 28 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.52859550 |
| 29 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.51210730 |
| 30 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.39787893 |
| 31 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.36557393 |
| 32 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.35248126 |
| 33 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.34113701 |
| 34 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.33105273 |
| 35 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.29882259 |
| 36 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.28766761 |
| 37 | Carbon metabolism_Homo sapiens_hsa01200 | 1.20823702 |
| 38 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.20196269 |
| 39 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.19740373 |
| 40 | Protein export_Homo sapiens_hsa03060 | 1.17466143 |
| 41 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.17007886 |
| 42 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.12732503 |
| 43 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.11733325 |
| 44 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.09397215 |
| 45 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.07444743 |
| 46 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.06350994 |
| 47 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.05017865 |
| 48 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.98152352 |
| 49 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.94881595 |
| 50 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.93692717 |
| 51 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.91939198 |
| 52 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.86566069 |
| 53 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.86141571 |
| 54 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.85666381 |
| 55 | Proteasome_Homo sapiens_hsa03050 | 0.85330039 |
| 56 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.84107726 |
| 57 | Retinol metabolism_Homo sapiens_hsa00830 | 0.83976780 |
| 58 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.83280927 |
| 59 | Metabolic pathways_Homo sapiens_hsa01100 | 0.81167950 |
| 60 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.78542101 |
| 61 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.76972630 |
| 62 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.75330248 |
| 63 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.74782266 |
| 64 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.74518605 |
| 65 | Circadian rhythm_Homo sapiens_hsa04710 | 0.73248658 |
| 66 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.71461282 |
| 67 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.69172694 |
| 68 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.66679838 |
| 69 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.66521842 |
| 70 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.65995916 |
| 71 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.63629080 |
| 72 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.58432986 |
| 73 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.57837808 |
| 74 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.57822893 |
| 75 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.56402734 |
| 76 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.52830212 |
| 77 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.52010937 |
| 78 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.51674366 |
| 79 | Bile secretion_Homo sapiens_hsa04976 | 0.51486838 |
| 80 | GABAergic synapse_Homo sapiens_hsa04727 | 0.50599877 |
| 81 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.50106270 |
| 82 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.49423937 |
| 83 | Phagosome_Homo sapiens_hsa04145 | 0.48391734 |
| 84 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.46000303 |
| 85 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.45857097 |
| 86 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.45515111 |
| 87 | Insulin secretion_Homo sapiens_hsa04911 | 0.43394459 |
| 88 | Circadian entrainment_Homo sapiens_hsa04713 | 0.40725905 |
| 89 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.40029403 |
| 90 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.39609594 |
| 91 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.39434756 |
| 92 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.38378954 |
| 93 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.36982385 |
| 94 | Lysosome_Homo sapiens_hsa04142 | 0.36686369 |
| 95 | Renin secretion_Homo sapiens_hsa04924 | 0.35985232 |
| 96 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.34538031 |
| 97 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.34179057 |
| 98 | ABC transporters_Homo sapiens_hsa02010 | 0.33648596 |
| 99 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.31578106 |
| 100 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.30251637 |
| 101 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.29782883 |
| 102 | Nicotine addiction_Homo sapiens_hsa05033 | 0.26235239 |
| 103 | Sulfur relay system_Homo sapiens_hsa04122 | 0.25932376 |
| 104 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.25351956 |
| 105 | Galactose metabolism_Homo sapiens_hsa00052 | 0.24932229 |
| 106 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.24077631 |
| 107 | Morphine addiction_Homo sapiens_hsa05032 | 0.22367886 |
| 108 | Mineral absorption_Homo sapiens_hsa04978 | 0.21838884 |
| 109 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.20926186 |
| 110 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.16488735 |
| 111 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.13649593 |
| 112 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.11628740 |
| 113 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.11138356 |
| 114 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.10712379 |

